vs
Dominari Holdings Inc.（DOMH）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Dominari Holdings Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.5倍（$30.1M vs $19.6M），STANDARD BIOTOOLS INC.净利率更高（-177.4% vs -438.1%，领先260.7%），Dominari Holdings Inc.同比增速更快（220.4% vs -11.5%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
DOMH vs LAB — 直观对比
营收规模更大
DOMH
是对方的1.5倍
$19.6M
营收增速更快
DOMH
高出231.9%
-11.5%
净利率更高
LAB
高出260.7%
-438.1%
两年增速更快
DOMH
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $19.6M |
| 净利润 | $-131.8M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | -8.9% | -168.5% |
| 净利率 | -438.1% | -177.4% |
| 营收同比 | 220.4% | -11.5% |
| 净利润同比 | -12426.2% | -28.8% |
| 每股收益（稀释后） | $-6.94 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHLAB
| Q4 25 | $30.1M | — | ||
| Q3 25 | $50.8M | $19.6M | ||
| Q2 25 | $34.1M | $21.8M | ||
| Q1 25 | $8.1M | $40.8M | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $4.0M | $22.1M | ||
| Q2 24 | $6.2M | $22.5M | ||
| Q1 24 | $1.4M | $45.5M |
净利润DOMHLAB
| Q4 25 | $-131.8M | — | ||
| Q3 25 | $125.2M | $-34.7M | ||
| Q2 25 | $16.6M | $-33.5M | ||
| Q1 25 | $-32.5M | $-26.0M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-4.2M | $-26.9M | ||
| Q2 24 | $-6.1M | $-45.7M | ||
| Q1 24 | $-5.4M | $-32.2M |
毛利率DOMHLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率DOMHLAB
| Q4 25 | -8.9% | — | ||
| Q3 25 | -3.1% | -168.5% | ||
| Q2 25 | -57.0% | -118.1% | ||
| Q1 25 | -394.6% | -80.8% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -79.1% | -120.9% | ||
| Q2 24 | -44.3% | -134.5% | ||
| Q1 24 | -205.2% | -132.2% |
净利率DOMHLAB
| Q4 25 | -438.1% | — | ||
| Q3 25 | 246.4% | -177.4% | ||
| Q2 25 | 48.7% | -153.7% | ||
| Q1 25 | -400.5% | -63.8% | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | -104.2% | -122.0% | ||
| Q2 24 | -99.1% | -203.3% | ||
| Q1 24 | -398.0% | -70.6% |
每股收益（稀释后）DOMHLAB
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | $-0.09 | ||
| Q2 25 | $1.12 | $-0.09 | ||
| Q1 25 | $-3.02 | $-0.07 | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $-0.67 | $-0.07 | ||
| Q2 24 | $-1.01 | $-0.12 | ||
| Q1 24 | $-0.91 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $69.4M | $399.7M |
| 总资产 | $112.9M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHLAB
| Q4 25 | $80.5M | — | ||
| Q3 25 | $176.2M | $129.4M | ||
| Q2 25 | $28.2M | $158.6M | ||
| Q1 25 | $18.9M | $150.9M | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $7.2M | $210.6M | ||
| Q2 24 | $12.1M | $269.8M | ||
| Q1 24 | $7.1M | $287.1M |
总债务DOMHLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益DOMHLAB
| Q4 25 | $69.4M | — | ||
| Q3 25 | $210.2M | $399.7M | ||
| Q2 25 | $88.6M | $424.5M | ||
| Q1 25 | $42.4M | $454.6M | ||
| Q4 24 | $39.9M | — | ||
| Q3 24 | $38.3M | $489.3M | ||
| Q2 24 | $42.4M | $510.3M | ||
| Q1 24 | $47.7M | $577.3M |
总资产DOMHLAB
| Q4 25 | $112.9M | — | ||
| Q3 25 | $223.4M | $539.6M | ||
| Q2 25 | $109.3M | $557.0M | ||
| Q1 25 | $52.3M | $579.6M | ||
| Q4 24 | $47.1M | — | ||
| Q3 24 | $43.4M | $681.5M | ||
| Q2 24 | $49.1M | $708.7M | ||
| Q1 24 | $52.2M | $777.7M |
负债/权益比DOMHLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流DOMHLAB
| Q4 25 | $22.7M | — | ||
| Q3 25 | $-4.9M | $-22.2M | ||
| Q2 25 | $-353.0K | $-20.7M | ||
| Q1 25 | $1.2M | $-30.3M | ||
| Q4 24 | $-16.7M | — | ||
| Q3 24 | $-4.7M | $-27.9M | ||
| Q2 24 | $1.4M | $-39.0M | ||
| Q1 24 | $-8.6M | $-62.5M |
自由现金流DOMHLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率DOMHLAB
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度DOMHLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
现金转化率DOMHLAB
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
